« Previous
Next »
Journal of Oral and Maxillofacial Surgery
Volume 67, Issue 5
, Pages
943-950
, May 2009
Outcome of Surgical Management of Bisphosphonate-Related Osteonecrosis of the Jaws: Review of 33 Surgical Cases
To access this article, please choose from the options below
David C. Stanton is a consultant for a law firm, on behalf of Novartis, the manufacturer of Aredia and Zometa.
PII: S0278-2391(09)00116-5
doi: 10.1016/j.joms.2008.12.057
© 2009 American Association of Oral and Maxillofacial Surgeons. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Oral and Maxillofacial Surgery
Volume 67, Issue 5
, Pages
943-950
, May 2009
